Pyxis Oncology builds a differentiated portfolio of biologics, including antibody-drug conjugates and immunotherapies, to improve the lives of patients with difficult-to-treat cancers.

Register for Details

For more details on financing and valuation for Pyxis Oncology, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Pyxis Oncology's ticker symbol?


What is Pyxis Oncology's stock price?

1.84 as of 9/27/23

Learn more about Pyxis Oncology

Forge green plus iconForge green minus icon

When was Pyxis Oncology founded?

Pyxis Oncology was founded in 2018.
Updated on: Jun 12, 2022